AMFPF vs ZYXI
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMFPF is a Hold and ZYXI is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AMFPF’s FA Score shows that 0 FA rating(s) are green whileZYXI’s FA Score has 1 green FA rating(s).
- AMFPF’s FA Score: 0 green, 5 red.
- ZYXI’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AMFPF’s TA Score shows that 3 TA indicator(s) are bullish while ZYXI’s TA Score has 3 bullish TA indicator(s).
- AMFPF’s TA Score: 3 bullish, 3 bearish.
- ZYXI’s TA Score: 3 bullish, 5 bearish.
Price Growth
AMFPF (@Medical Distributors) experienced а +4.01% price change this week, while ZYXI (@Medical Distributors) price change was +1.35% for the same time period.
The average weekly price growth across all stocks in the @Medical Distributors industry was +0.86%. For the same industry, the average monthly price growth was +2.51%, and the average quarterly price growth was +147.05%.
Reported Earning Dates
ZYXI is expected to report earnings on Feb 27, 2025.
Industries' Descriptions
@Medical Distributors (+0.86% weekly)Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.
| AMFPF | ZYXI | AMFPF / ZYXI | |
| Capitalization | 8.23B | 398M | 2,068% |
| EBITDA | 520M | 17.9M | 2,905% |
| Gain YTD | -6.801 | -24.242 | 28% |
| P/E Ratio | 40.21 | 46.30 | 87% |
| Revenue | 2.22B | 184M | 1,209% |
| Total Cash | 198M | 44.6M | 444% |
| Total Debt | 1.58B | 76.2M | 2,068% |
AMFPF | ZYXI | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 38 Fair valued | 96 Overvalued | |
PROFIT vs RISK RATING 1..100 | 95 | 100 | |
SMR RATING 1..100 | 58 | 69 | |
PRICE GROWTH RATING 1..100 | 62 | 56 | |
P/E GROWTH RATING 1..100 | 60 | 7 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
AMFPF's Valuation (38) in the null industry is somewhat better than the same rating for ZYXI (96) in the Medical Specialties industry. This means that AMFPF’s stock grew somewhat faster than ZYXI’s over the last 12 months.
AMFPF's Profit vs Risk Rating (95) in the null industry is in the same range as ZYXI (100) in the Medical Specialties industry. This means that AMFPF’s stock grew similarly to ZYXI’s over the last 12 months.
AMFPF's SMR Rating (58) in the null industry is in the same range as ZYXI (69) in the Medical Specialties industry. This means that AMFPF’s stock grew similarly to ZYXI’s over the last 12 months.
ZYXI's Price Growth Rating (56) in the Medical Specialties industry is in the same range as AMFPF (62) in the null industry. This means that ZYXI’s stock grew similarly to AMFPF’s over the last 12 months.
ZYXI's P/E Growth Rating (7) in the Medical Specialties industry is somewhat better than the same rating for AMFPF (60) in the null industry. This means that ZYXI’s stock grew somewhat faster than AMFPF’s over the last 12 months.
| AMFPF | ZYXI | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 43% | N/A |
| Stochastic ODDS (%) | 4 days ago 29% | 4 days ago 81% |
| Momentum ODDS (%) | 4 days ago 28% | 4 days ago 81% |
| MACD ODDS (%) | 4 days ago 18% | 4 days ago 83% |
| TrendWeek ODDS (%) | 4 days ago 25% | 4 days ago 82% |
| TrendMonth ODDS (%) | 4 days ago 26% | 4 days ago 84% |
| Advances ODDS (%) | N/A | 14 days ago 80% |
| Declines ODDS (%) | N/A | 6 days ago 78% |
| BollingerBands ODDS (%) | 5 days ago 50% | N/A |
| Aroon ODDS (%) | 4 days ago 45% | 4 days ago 80% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| JLPCX | 15.31 | 0.18 | +1.19% |
| JPMorgan US Large Cap Core Plus C | |||
| MRIMX | 22.55 | 0.26 | +1.17% |
| Victory Integrity Mid-Cap Value R6 | |||
| APGAX | 97.02 | 0.96 | +1.00% |
| AB Large Cap Growth A | |||
| GTTUX | 55.17 | 0.48 | +0.88% |
| Goldman Sachs Small Cp Val Insghts R6 | |||
| TNYRX | 10.25 | 0.03 | +0.29% |
| 1290 Loomis Sayles Multi-Asset Income R | |||
AMFPF and
Correlation & Price change
A.I.dvisor tells us that AMFPF and ZYXI have been poorly correlated (+10% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMFPF and ZYXI's prices will move in lockstep.
| Ticker / NAME | Correlation To AMFPF | 1D Price Change % | ||
|---|---|---|---|---|
| AMFPF | 100% | N/A | ||
| ZYXI - AMFPF | 10% Poorly correlated | -1.79% | ||
| COSM - AMFPF | 2% Poorly correlated | -5.82% | ||
| NSVGF - AMFPF | 1% Poorly correlated | N/A | ||
| SHPMY - AMFPF | 0% Poorly correlated | N/A | ||
| MAHLY - AMFPF | 0% Poorly correlated | N/A | ||
More | ||||
ZYXI and
Correlation & Price change
A.I.dvisor indicates that over the last year, ZYXI has been loosely correlated with OMI. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ZYXI jumps, then OMI could also see price increases.
| Ticker / NAME | Correlation To ZYXI | 1D Price Change % | ||
|---|---|---|---|---|
| ZYXI | 100% | -1.79% | ||
| OMI - ZYXI | 39% Loosely correlated | -0.79% | ||
| HSIC - ZYXI | 17% Poorly correlated | +1.26% | ||
| PDCO - ZYXI | 14% Poorly correlated | -0.16% | ||
| COSM - ZYXI | 11% Poorly correlated | -5.82% | ||
| GEG - ZYXI | 11% Poorly correlated | +2.70% | ||
More | ||||